A role for IL-33-activated ILC2s in eosinophilic vasculitis

Authors

Maya E Kotas, University of California, San Francisco
Jérémie Dion, Cochin Hospital
Steven Van Dyken, Washington University School of Medicine in St. Louis
Roberto R Ricardo-Gonzalez, University of California, San Francisco
Claire J Danel, Bichat Hospital
Camille Taillé, Bichat Hospital
Luc Mouthon, Cochin Hospital
Richard M Locksley, University of California, San Francisco
Benjamin Terrier, Cochin Hospital

Journal

JCI Insight

Publication Date

6-22-2021

Volume

6

Issue

12

First Page

e143366

Document Type

Open Access Publication

DOI

10.1172/jci.insight.143366

Rights and Permissions

Kotas ME, Dion J, Van Dyken S, Ricardo-Gonzalez RR, Danel CJ, Taillé C, Mouthon L, Locksley RM, Terrier B. A role for IL-33-activated ILC2s in eosinophilic vasculitis. JCI Insight. 2021 Jun 22;6(12):e143366. doi: 10.1172/jci.insight.143366.

Recommended Citation

Kotas, Maya E; Dion, Jérémie; Van Dyken, Steven; Ricardo-Gonzalez, Roberto R; Danel, Claire J; Taillé, Camille; Mouthon, Luc; Locksley, Richard M; and Terrier, Benjamin, "A role for IL-33-activated ILC2s in eosinophilic vasculitis." JCI Insight. 6, 12. e143366 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10645